InspireMD Initiates U.S. Recall of CGuard Prime System
MIAMI, May 1, 2026 InspireMD, Inc. announced a voluntary U.S. recall of its CGuard® Prime 135 cm carotid stent...
Medical Devices, Diagnostics, Radiation-Emitting Products
InspireMD, Inc. Secures FDA IDE for CGUARDIANS III
MIAMI, May 1, 2026 InspireMD, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its...
Vector Science & Therapeutics Files Patent for Platform
MEQUON, Wis., May 1, 2026 Vector Science & Therapeutics, Inc. has announced the filing of a provisional patent application...
Everads Injector Shows Strong Results in Retinal Study
Tel Aviv, Israel | May 3, 2026 Everads Therapy has announced the publication of first-in-human clinical data for its...
Sonire Therapeutics Launches U.S. HIFU Trial in Cancer
PALO ALTO, California, May 1, 2026 Sonire Therapeutics Inc. announced the initiation of its first U.S. clinical trial, SUNRISE-II,...
Alcresta Therapeutics Shows RELiZORBneo Benefit Data
WALTHAM, Massachusetts, May 1, 2026 Alcresta Therapeutics, Inc. announced the publication of preclinical data evaluating its RELiZORBneo cartridge in...
Zeta Surgical Wins FDA Clearance for Neuro Navigation
Boston, USA | May 1, 2026 Zeta Surgical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
SetPoint Medical Starts MS Study for Neuroimmune Therapy
VALENCIA, California, April 30, 2026 SetPoint Medical announced the first patients enrolled in a pilot clinical study evaluating its...
Theradaptive Gains FDA Approval for Regenerative Spine Therapy
FREDERICK, MARYLAND, April 30, 2026 Theradaptive has received U.S. Food and Drug Administration (FDA) authorization to advance its OASIS...
AVITA Medical Secures TGA Approval for RECELL GO in Australia
VALENCIA, Calif., April 29, 2026 AVITA Medical, Inc. has announced that its next-generation wound care platform RECELL GO® has...